ITMI20021455A1 - Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico - Google Patents

Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico

Info

Publication number
ITMI20021455A1
ITMI20021455A1 IT2002MI001455A ITMI20021455A ITMI20021455A1 IT MI20021455 A1 ITMI20021455 A1 IT MI20021455A1 IT 2002MI001455 A IT2002MI001455 A IT 2002MI001455A IT MI20021455 A ITMI20021455 A IT MI20021455A IT MI20021455 A1 ITMI20021455 A1 IT MI20021455A1
Authority
IT
Italy
Prior art keywords
phospholipidic
lexitropsins
formulations
preparation
therapeutic use
Prior art date
Application number
IT2002MI001455A
Other languages
English (en)
Inventor
Ugo Raffaello Citernesi
Federico Arcamone
Original Assignee
Ugo Raffaello Citernesi
Federico Arcamone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ugo Raffaello Citernesi, Federico Arcamone filed Critical Ugo Raffaello Citernesi
Priority to IT2002MI001455A priority Critical patent/ITMI20021455A1/it
Publication of ITMI20021455A0 publication Critical patent/ITMI20021455A0/it
Priority to PCT/EP2003/006745 priority patent/WO2004004691A1/en
Priority to JP2004518585A priority patent/JP2006505506A/ja
Priority to EP03762519A priority patent/EP1536771A1/en
Priority to US10/519,889 priority patent/US20060067997A1/en
Priority to AU2003250849A priority patent/AU2003250849A1/en
Priority to CA002491257A priority patent/CA2491257A1/en
Publication of ITMI20021455A1 publication Critical patent/ITMI20021455A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IT2002MI001455A 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico ITMI20021455A1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT2002MI001455A ITMI20021455A1 (it) 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico
PCT/EP2003/006745 WO2004004691A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
JP2004518585A JP2006505506A (ja) 2002-07-02 2003-06-26 レキシトロプシンのリン脂質複合体、その製造及び治療剤への使用
EP03762519A EP1536771A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
US10/519,889 US20060067997A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
AU2003250849A AU2003250849A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
CA002491257A CA2491257A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001455A ITMI20021455A1 (it) 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico

Publications (2)

Publication Number Publication Date
ITMI20021455A0 ITMI20021455A0 (it) 2002-07-02
ITMI20021455A1 true ITMI20021455A1 (it) 2004-01-02

Family

ID=11450127

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI001455A ITMI20021455A1 (it) 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico

Country Status (7)

Country Link
US (1) US20060067997A1 (it)
EP (1) EP1536771A1 (it)
JP (1) JP2006505506A (it)
AU (1) AU2003250849A1 (it)
CA (1) CA2491257A1 (it)
IT (1) ITMI20021455A1 (it)
WO (1) WO2004004691A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031015A1 (it) * 2003-05-20 2004-11-21 Naxospharma S R L Poli-(amminopirrolcarbossammidi) per uso nella profilassi e nel trattamento delle endoparassitosi animali e loro composizioni con ciclodestrine.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517922D0 (en) * 1985-07-16 1985-08-21 Erba Farmitalia Carboxamido derivatives
US6187572B1 (en) * 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
NZ514133A (en) * 1996-10-15 2001-09-28 Liposome Co Inc N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
CA2388674C (en) * 1999-11-16 2005-01-25 Oncozyme Pharma Inc Inhibitors of endo-exonuclease activity for treating cancer
JP2004501915A (ja) * 2000-06-27 2004-01-22 ジェネラブス・テクノロジーズ・インコーポレーテッド 抗菌、抗真菌または抗腫瘍活性を有する新規な化合物

Also Published As

Publication number Publication date
CA2491257A1 (en) 2004-01-15
AU2003250849A1 (en) 2004-01-23
US20060067997A1 (en) 2006-03-30
ITMI20021455A0 (it) 2002-07-02
JP2006505506A (ja) 2006-02-16
WO2004004691A1 (en) 2004-01-15
EP1536771A1 (en) 2005-06-08

Similar Documents

Publication Publication Date Title
IS7714A (is) Lyfjasamsetningar úr módafíníl
CY2013043I1 (el) Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv
NO20044402L (no) Kombinasjonsbehandling av kemokine-medierte sykdommer
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
NO20055652D0 (no) Laktatinneholdende farmasoytisk preparat og anvendelse av dette
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
ITMI20001732A0 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
NO20053874L (no) Formulering og metoder for behandling av thrombocytemi
NO20043370L (no) N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
PT1594544T (pt) Composições orais de fenretinida tendo biodisponibilidade aumentada e métodos de utilização das mesmas
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IL162937A0 (en) Pravastatin pharmaceutical formulations and methods of their use
EP1416925A4 (en) APPLICATIONS OF TARGETED OXIDATIVE THERAPEUTIC FORMULATION IN ARTERIOSCLEROSIS
EP1675619A4 (en) EXTENDED RELEASE ARGININE FORMULATIONS, METHODS OF MAKING, AND USES
EP1531795A4 (en) FORMULATIONS LIMITING THE EXTENSION OF PULMONARY INFECTIONS
ATE489069T1 (de) Mundpflegezusammensetzungen und -verfahren
ZA200603542B (en) Oral formulations of desoxypeganine and uses thereof
EE200300328A (et) IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks